-
ESMO Asia 2024 | Dr. Danbo Wang: Advancing Immunotherapy for Recurrent or Metastatic Cervical Cancer
At the European Society for Medical Oncology Asia Congress 2024 (ESMO Asia 2024), Dr. Danbo Wang from Liaoning Cancer Hospital presented the latest findings from the DUBHE-C-204 study during the Gynecological Oncology Oral Abstracts session (Abstract No. 373O). Oncology Frontier had the privilege of interviewing Professor Wang on-site to discuss the study’s key findings and…
-
Tailored Guidance: Stratified Management and Comprehensive Decision-Making for Advanced Renal Cancer in China — Dr. Guohai Shi’s Interpretation of the 2024 CSCO Guidelines on Advanced RCC Treatment
Since the release of the CSCO Renal Cancer Diagnosis and Treatment Guidelines in 2013, the guidelines have undergone eight updates, significantly advancing the standardization of renal cancer management in China. Over the past year, significant progress has been made globally and domestically in renal cancer treatment, particularly in medical therapies that have influenced clinical practice.…
-
Dr. Jian Huang: Advances in Functional Breast Surgery and Translational Research in Breast Cancer | 2024 Straits Breast Cancer Forum
During the recent 2024 Straits Breast Cancer Forum and Fujian Medical Association Breast Disease Division Meeting, Oncology Frontier had the privilege of inviting Dr. Jian Huang from The Second Affiliated Hospital of Zhejiang University School of Medicine. He shared in-depth insights into advancements in neoadjuvant therapy for breast cancer downstaging and breast conservation, the significance…
-
2024 Lung Cancer Precision Therapy Academic Conference | Professor Jianhua Chang Highlights Key Takeaways from the 2024 Lung Cancer Precision Therapy
Oncology Frontier ：The Lung Cancer Precision Therapy Academic Conference has become a recognized academic brand. Could you tell us about its origins, development, and goals? What impact do you hope…
-
SABCS 2024 | Dr. Qingyuan Zhang: A New Breakthrough with SIM0270 in ER+/HER2- Advanced Breast Cancer
At the recent San Antonio Breast Cancer Symposium (SABCS), Professor Jiong Wu from Fudan University Shanghai Cancer Center presented the latest findings from a Phase I study on SIM0270 (Abstract Number: PS14-03). SIM0270, an innovative brain-penetrant oral selective estrogen receptor degrader (SERD), demonstrated significant clinical efficacy and excellent tolerability in patients with ER+/HER2- advanced breast…
-
Dr. Benlong Yang: Advances in Precision Treatment for HER2-Positive Breast Cancer | 2024 Straits Breast Cancer Forum
With the rapid advancement of medical technology, the concept of precision medicine has been widely applied in the diagnosis and treatment of breast cancer. At the 47th San Antonio Breast Cancer Symposium (SABCS) in 2024, Chinese research gained significant attention, showcasing groundbreaking achievements in breast cancer treatment. During the “2024 Straits Breast Forum and the…
-
Deep Learning-Based Prognostication for Hepatocellular Carcinoma: A Multimodal Imaging Approach
Study Design This multicenter study involved 1,231 patients with histology-confirmed HCC who underwent liver resection. The internal cohort, comprising patients from four centers in Chinese Hong Kong, was divided into…
-
JAMA Network Open丨Dr. Fanpu Ji’s Team: Trends and Projections of Hepatocellular Carcinoma Mortality Rates in the U.S.
Background and Key Findings Globally, the burden of liver cancer is significant. In 2020, it was the sixth most common cancer and the third leading cause of cancer deaths worldwide.…
Connecting Medical Expertise through Media